| Hans-Günter Meyer-Thompson | Buprenorphin
Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization.
Population pharmacokinetics of buprenorphine and naloxone sublingual combination in Chinese healthy volunteers and patients with opioid use disorder: Model-based dose optimization.
Gu M, Li A, Mak W, Dong F, Xu N, Zhang J, Shi Y, Zheng N, Tang Z, He Q, Ruan C, Guo W, Xiang X, Wang C, Han B, Zhu X.
Front Pharmacol. 2023 Jan 19;14:1089862. doi: 10.3389/fphar.2023.1089862. PMID: 36744255; PMCID: PMC9893638.